Michael Zalutsky

Michael Zalutsky

Duke University - Durham / United States
Medical and Health Sciences / Nuclear Medicine
AD Scientific Index ID: 1290817
person_outline Michael Zalutsky's MOST POPULAR ARTICLES
1-) Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomasCJ Wikstrand, LP Hale, SK Batra, ML Hill, PA Humphrey, SN Kurpad, ...Cancer research 55 (14), 3140-3148, 19956211995
2-) Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma.PA Humphrey, AJ Wong, B Vogelstein, MR Zalutsky, GN Fuller, GE Archer, ...Proceedings of the National Academy of Sciences 87 (11), 4207-4211, 19904471990
3-) Clinical experience with α-particle–emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6MR Zalutsky, DA Reardon, G Akabani, RE Coleman, AH Friedman, ...Journal of Nuclear Medicine 49 (1), 30-38, 20083832008
4-) Pinhole collimation for ultra-high-resolution, small-field-of-view SPECTRJ Jaszczak, J Li, H Wang, MR Zalutsky, RE ColemanPhysics in Medicine & Biology 39 (3), 425, 19943861994
5-) Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermiaDE Meyer, GA Kong, MW Dewhirst, MR Zalutsky, A ChilkotiCancer research 61 (4), 1548-1554, 20013632001